Pancoast’s tumour is a rare and challenging type of lung cancer that grows at the very top of the lung, where it often goes unnoticed until it affects nearby nerves, bones, and blood vessels. Unlike typical lung cancers that cause coughing, this tumour typically announces itself through severe shoulder pain and arm weakness, making early diagnosis particularly difficult.

Understanding the Long-Term Outlook

A diagnosis of Pancoast’s tumour brings with it many questions about what lies ahead. This is a disease that, while not curable, has become much more manageable than in the past. The survival outlook depends heavily on several factors, including how far the cancer has spread at the time of discovery, whether it has reached the lymph nodes, and whether complete surgical removal is possible.^[1]

Statistics show that for patients who undergo the full course of treatment—including chemotherapy, radiation, and surgery—survival rates typically range from 30% to 50% at the five-year mark. This represents a significant improvement from earlier decades when Pancoast tumours were considered universally fatal.^[19] The best outcomes occur when the tumour can be completely removed surgically and when there is no involvement of the lymph nodes.^[11]

The average age at diagnosis falls in the sixth decade of life, typically between 60 and 70 years old, and the disease occurs more commonly in men than women.^[3][6] Because these tumours grow in the narrow space at the top of the chest, they tend to invade surrounding structures early in their development. This means that even when diagnosed relatively early, they may already be affecting ribs, vertebrae, nerves, or blood vessels.^[8]

How the Disease Progresses Without Treatment

When a Pancoast tumour is left untreated, it follows a pattern of growth that is particularly destructive because of its location. The tumour begins in the uppermost part of the lung, a region called the apex, which sits just above the first rib. From this starting point, the cancer grows outward rather than deeper into the lung tissue itself.^[8]

The bulk of an untreated Pancoast tumour extends outside the lung into the surrounding chest structures. It spreads in a characteristic pattern, invading the ribs, the upper portion of the backbone, the network of nerves that control the arm and hand (called the brachial plexus), and the blood vessels that supply blood to the arm. The tumour can also affect the sympathetic nerve chain that runs alongside the spine, leading to a distinctive set of symptoms affecting the face and eye.^[1][8]

As the disease advances without intervention, the pain typically worsens and spreads. What might start as a dull ache in the shoulder gradually intensifies and radiates down the arm, eventually reaching the hand. The muscles of the arm and hand begin to weaken and may waste away. Daily tasks that require hand coordination become increasingly difficult. In advanced stages, the tumour may extend into the neck or cause widespread damage to the spine.^[6]

Unlike other lung cancers, Pancoast tumours rarely cause typical respiratory symptoms in the early stages because they grow at the edge of the lung rather than in the airways. This means that warning signs like persistent cough, shortness of breath, or coughing up blood are often absent until late in the disease course.^[6][9] This absence of classic lung cancer symptoms is one reason why diagnosis is often delayed, sometimes for weeks or months.

Possible Complications and Unfavorable Developments

Patients with Pancoast’s tumour face a range of complications that can significantly affect their wellbeing. Many of these complications arise not from the tumour itself but from its invasion of critical structures in the upper chest.

One of the most characteristic complications is called Horner’s syndrome, which occurs when the tumour damages the sympathetic nerves that control certain functions in the face and eye. This syndrome causes a drooping eyelid on the affected side, a smaller pupil, decreased sweating on one side of the face, and sometimes a sunken appearance of the eye. Up to half of all patients with Pancoast tumours develop Horner’s syndrome at some point during their illness.^[1][9]

Nerve damage is another serious complication. As the tumour presses on or invades the brachial plexus—the bundle of nerves that sends signals from the spinal cord to the shoulder, arm, and hand—patients experience progressive weakness and loss of function. This can lead to loss of dexterity in the fingers, difficulty gripping objects, and eventually significant disability in using the affected arm.^[4][9]

The tumour can also invade bones, particularly the upper ribs and vertebrae. This invasion causes severe, unrelenting pain that may be difficult to control even with strong pain medications. In some cases, the structural integrity of the vertebrae becomes compromised, potentially leading to spinal instability.^[8][12]

Blood vessel involvement presents another set of challenges. When the tumour grows into the subclavian artery or vein—major blood vessels that supply the arm—it can cause swelling, reduced blood flow, and in severe cases, blood clots. This vascular involvement also makes surgical treatment more complex and risky.^[4][8]

Like other cancers, Pancoast tumours can spread to lymph nodes and distant organs. When cancer cells travel to the adrenal gland, liver, bones in other parts of the body, or the brain, treatment becomes more challenging and the prognosis worsens considerably.^[19]

Impact on Daily Life and Personal Wellbeing

Living with Pancoast’s tumour affects nearly every aspect of daily existence. The physical symptoms alone create substantial challenges, but the emotional and social impacts are equally profound.

Pain is often the dominant feature of life with this disease. The severe, chronic pain in the shoulder, arm, and hand can make even simple activities exhausting. Tasks that most people take for granted—dressing, eating, writing, or using a phone—become difficult or impossible when one arm is weak and painful. Sleep is frequently disrupted because lying down in certain positions aggravates the pain. Many patients find themselves awake at night, unable to find a comfortable position.^[5][9]

The loss of hand function has particularly significant consequences. For people whose work involves manual labor, detailed handwork, or even typing at a computer, the weakness and loss of coordination can make continuing their occupation impossible. This often leads to job loss or early retirement, with accompanying financial stress and loss of identity and purpose.^[5]

Treatment itself demands considerable time and energy. The standard treatment approach involves weeks of chemotherapy and daily radiation treatments, followed by major surgery and a recovery period. During active treatment, patients must make frequent trips to medical facilities, sometimes requiring travel to specialized cancer centers that may be far from home. The side effects of chemotherapy—nausea, fatigue, and increased risk of infection—add another layer of difficulty to daily life.^[10][11]

Emotionally, the diagnosis brings fear, uncertainty, and grief. Patients must come to terms with having an incurable form of cancer while simultaneously maintaining hope that treatment will extend their life. The unusual nature of the symptoms—severe arm and shoulder pain without obvious lung problems—can lead to initial misdiagnosis, and some patients spend weeks or months being treated for shoulder or neck problems before the true diagnosis is made. This delay can add to feelings of frustration and anxiety.^[5][22]

Social relationships often change. Friends and family may struggle to understand the severity of the condition or may not know how to help. Some patients find that their social circle shrinks as they become less able to participate in activities they once enjoyed. Hobbies that require physical activity or use of both arms may need to be abandoned or significantly modified.

However, many patients find ways to adapt and cope. Working with occupational therapists can help identify assistive devices and techniques for managing daily tasks with limited use of one arm. Pain management specialists can offer strategies beyond medication, including nerve blocks and other interventions. Support groups, whether in person or online, provide connection with others facing similar challenges and can be invaluable sources of practical advice and emotional support.^[19]

Supporting Family Members Through Clinical Trials

For families dealing with Pancoast’s tumour, understanding the role of clinical trials can be both empowering and confusing. Clinical trials represent the pathway through which new treatments are tested and eventually become available to all patients. Family members can play a crucial role in helping their loved one navigate the possibility of trial participation.

Pancoast tumours, being rare, are the subject of ongoing research aimed at improving treatment outcomes. Current research is exploring new combinations of therapies, including the addition of immunotherapy—treatments that harness the body’s immune system to fight cancer—to the standard regimen of chemotherapy, radiation, and surgery. Some studies are examining whether adding immunotherapy before or after surgery can improve survival rates.^[12][21]

Families should understand that participation in a clinical trial is always voluntary and that patients have the right to withdraw at any time. Trials have strict inclusion and exclusion criteria, meaning not every patient will qualify for every study. Factors such as the stage of cancer, previous treatments received, other health conditions, and even age may determine eligibility.

Family members can help by assisting with research into available trials. Major cancer centers maintain databases of ongoing clinical trials, and specialized cancer organizations often have search tools that allow patients and families to find relevant studies. During medical appointments, families can advocate for their loved one by asking the medical team whether any clinical trials might be appropriate options.^[11]

It is important for families to understand that participating in a trial does not mean receiving inferior care or being treated as a “guinea pig.” All clinical trials have rigorous oversight to protect patient safety, and participants often receive more intensive monitoring than they would with standard treatment. However, trials do involve some uncertainty—new treatments may not work as well as hoped, and unforeseen side effects may occur.

Families can provide practical support during trial participation by helping keep track of appointment schedules, organizing medical records, taking notes during doctor visits, and monitoring for side effects. The logistics of trial participation can be complex, with frequent assessments and careful documentation required. Having a family member to help manage these details can reduce stress for the patient.

Transportation to and from trial sites can be a significant burden, especially if the specialized center conducting the trial is located far from home. Some trials offer assistance with travel expenses, but families should inquire about this upfront and plan accordingly. In some cases, certain trial visits can be coordinated with local healthcare providers to reduce travel burden.

Emotional support remains crucial throughout the trial process. Participating in research can be stressful, particularly during waiting periods for results or if the treatment is not working as hoped. Family members can provide reassurance, help maintain perspective, and celebrate small victories along the way. Simply being present and engaged in the process makes a meaningful difference to patients facing this challenging disease.